Tag: EMA
-
Meningioma Warning For Depo-Provera Recommended in Europe by Drug Regulator
Why Has This September 2024 European Medicines Agency (EMA) Action Not Been Followed by FDA in US? (Posted by Tom Lamb at Drug Injury Watch) One of the primary issues in the increasing number of Depo-Provera meningioma…
-
Syfovre Safety-Benefit Assessment by Europe’s Drug Regulator Differs From FDA
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing "significant risk of adverse events" (Posted by Tom Lamb at Drug Injury Watch) There seems to be some disagreement about the Syfovre safety-benefit assessment…
-
Ozempic Side Effects: Gallbladder Diseases, Thyroid Cancer, And Suicidal Thoughts
Diabetes and Weight-Loss Drug Ozempic Getting Scrutiny From European Drug Safety Regulator EMA ***See also: Ozempic Severe Gastric Side Effects Include Stomach Paralysis, Gastroparesis, And Intestinal Blockages (Posted by Tom Lamb at Drug Injury Watch)…
-
Xalkori Vision Side Effects for Pediatric Patients in Clinical Trials Were Seen at an Alarming Rate, Says EMA
Drug Safety Warning: Xalkori-Related Ocular Toxicity and Severe Visual Loss are Difficult to Detect in Children (Posted by Tom Lamb at Drug Injury Watch) Xalkori (crizotinib) is approved by the FDA for the treatment of:…
-
JAK Inhibitors Safety Review by European Drug Regulator EMA Announced in February 2022
Xeljanz, Rinvoq, and Olumiant as Treatments for Inflammatory Disorders Have Been Under Scrutiny by FDA in the US (Posted by Tom Lamb at Drug Injury Watch) In December 2021 there was a notable JAK inhibitors…
-
Gilenya Safety Alert November 2020: Cases of Acute Liver Failure Requiring Liver Transplant
European Medicines Agency (EMA) and Novartis Issue Dear Doctor Letter About Gilenya Label Change (Posted by Tom Lamb at DrugInjuryWatch.com) A recent periodic review of Gilenya safety data by the European Medicines…
-
Picato May Increase The Risk Of Skin Cancer As Side Effect, Says Drug Regulator Health Canada In July 2020
Picato Skin Cancer Risk Has Been Confirmed By European Drug Regulator; The FDA Is Still Investigating This Picato Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com) The topical gel drug Picato (ingenol…
-
Picato Skin Cancer Risk Findings Are Confirmed By European Drug Safety Panel In April 2020
FDA Investigation Of This Picato Drug Safety Issue Seems To Be Still Ongoing, Despite Picato Recall In Europe (Posted by Tom Lamb at DrugInjuryWatch.com) A European drug safety panel announced in April…
-
Beovu Vision-Related Side Effects Warnings Label Change Request By Novartis: News Report
This Is A Reversal Of March 2020 Novartis Position That Current Beovu Drug Label Provided Sufficient Warnings (Posted by Tom Lamb at DrugInjuryWatch.com) According to an April 2020 news report, Novartis has…